EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS093-09743 
Organism
Homo sapiens 
Tissue/cell
HL-60 
Coordinate
chr14:100533810-100535750 
TF binding sites/motifs
Number: 3             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
LMX1BMA0703.2chr14:100535497-100535508GATTTAATTAA+6.02
RxraMA0512.2chr14:100534607-100534621GGGTTCAAGGGTCA+6.48
Stat6MA0520.1chr14:100535144-100535159GGTTCCCAGGAAATG-6.24
Number of super-enhancer constituents: 29             
IDCoordinateTissue/cell
SE_11286chr14:100527733-100552220CD20
SE_11991chr14:100528275-100536445CD3
SE_13890chr14:100530746-100536506CD34_Primary_RO01536
SE_14353chr14:100530756-100536430CD34_Primary_RO01549
SE_14463chr14:100528321-100544145CD4_Memory_Primary_7pool
SE_15443chr14:100528456-100538683CD4_Memory_Primary_8pool
SE_15918chr14:100530600-100538177CD4_Naive_Primary_7pool
SE_16347chr14:100528476-100538536CD4_Naive_Primary_8pool
SE_16943chr14:100528605-100539908CD4p_CD225int_CD127p_Tmem
SE_17314chr14:100522811-100577622CD4p_CD25-_CD45RAp_Naive
SE_17820chr14:100526700-100553953CD4p_CD25-_CD45ROp_Memory
SE_18254chr14:100522443-100567666CD4p_CD25-_Il17-_PMAstim_Th
SE_19136chr14:100527567-100544242CD4p_CD25-_Il17p_PMAstim_Th17
SE_20272chr14:100528084-100544206CD56
SE_21009chr14:100528449-100538244CD8_Memory_7pool
SE_21590chr14:100528842-100538105CD8_Naive_7pool
SE_21926chr14:100528595-100551511CD8_Naive_8pool
SE_22530chr14:100526840-100544263CD8_primiary
SE_25362chr14:100526641-100552182DND41
SE_30973chr14:100529259-100544222Fetal_Thymus
SE_39460chr14:100528773-100538758Jurkat
SE_50771chr14:100533160-100536425Sigmoid_Colon
SE_53254chr14:100533119-100537616Small_Intestine
SE_55201chr14:100533106-100537534Thymus
SE_60205chr14:100529220-100541388Ly4
SE_60935chr14:100530749-100541346DHL6
SE_61706chr14:100529909-100542943Toledo
SE_62543chr14:100523524-100549949Tonsil
SE_66308chr14:100528773-100538758Jurkat
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr14100534854100535453
Enhancer Sequence
GTTGTGGGGC GTTTTTGTTT TTGTATTTTT TAGAGATGAG GTCTTGCTTT ATTGCCCAGG 60
CTGGCCTCAA ACTCCCGGGC TCGAGCAAGC CTCCTGCCTC AGCGGGACTA CAGGTGTGGG 120
CCACCACACC CAGCTAGCAT TGTTTTTATT GTTTCTGTTT CACAGGAGAG AGTAACTTGA 180
CAAGAGACAT AGCCAGTGAG TGATAGACCC AGGACTTGAA CCTGTGCCTC CTGACCACAG 240
ATGCTTTGCC CTTTTGCTCT TACGCCTGAA TTAGAGCTGC CTCTGTCCTC AGGGACTGGT 300
AGGGAGTGAG GAAGACAGCA CTCACAGAAA TGAGGAGGCG ACTGGCTGTG AGGACCCTGC 360
AGCACAGAGA GTAATAAGCA TAGACAGGAG GGGCAGTAAG AGTTGAGAAG TTGGGGACTG 420
TCAGGGAAGA CCTCAAAGAG AAAGTGGGAT CTCAGGTGAA CTTTGAAGAA TAGGGATGAT 480
TTTTTAGAAG GCACTGGCAG GCATCACAGG CAACCAGTCA CCCAGCGGCT GCTCTGGGTG 540
CTAGGGACAC AGTGGTAAAC AAGACAGGCA GTCTTGTCCT CAAACTGAGG GCAGAGTCGG 600
GAGGCAGAAT ATAGTCAAGA AACCATCAAC AAGAGACGTG AAAACAATAG AGCAGTGTGG 660
TAGAGAGTGA CTGGGCCACG CCTTAGGGGA CATGTGGGGA CATGAGGCAG CCATGCTAAA 720
ATCTGAAGGT TTTGGGGTGG AAAGGGCAGC AAGTATCCTC AGCTGGGGAC GAGGCCCTGA 780
GATAGGAATG GTTTGGTGGG TTCAAGGGTC AAGAAAAATA CAGAGGCTGG AGCAACATGA 840
AGAAGGAAGA GTGAAGGCAA ATAAGGGCAC AGAAGGCTTT ATCAGGCCCA ACGGCAAAGC 900
CTGCGAGCTG TGCTGAATTT AGCGCGTATG TCAGAATTTA GTTAGGGGAA GCCTTTGGAG 960
GGAGGGTTTG AAGCAAAGGG AAAGACATCT CATAGAAGCT TAAGAAAATC ACTCTGGGCC 1020
CTGTGTGGAT AATGGCTGGC AGTGTGGCAA GAATGGAGGC AGGATGACCT CTTGGGAGGC 1080
TACCGCAGTC ATCCAGGTAA GAGGTGAGGG TGGTTTGGGC CAGCAGTGGA GCAGTCAGGG 1140
TAGGCGGTGA GAAGTCACCA GATTCAGGAA GTGCCGTGGT GCTGTAGCCT CCAGGACTAT 1200
CTGGTGGATC ACACATGGGC GTGGGGGAAA CATGAGTCAG ACATGGCTTA GGTGGGTGGT 1260
GATTCCTTTC ACCACGCTGG GGCAGCTGGG GTGCTAGCTG GAAGAATCTG TAGAGGTGTG 1320
GGCCTAGCAG CACAGGTTCC CAGGAAATGT GGGTTGAACA AGGCTGACCT GAGCAGGAAG 1380
TAGCTGAGGT CGCGGTGCAG CAGCAGGAAA CGTGATATGG ATGTGTGATA TGTCTGCCAC 1440
TTTTGGGGCC AGCCAGTTAA TTTCGTTTCC TTCCCTGGTC TCTCTGTTGT CTTTGGTAGG 1500
CTGTGGGTTT TTCCGAAGCA CGTACTATCT TCTAACGTAT TATAGAACTT ACTTGTTCTA 1560
CTGTATACTG TCTTTACCCC TCAAGAATGT AAACTCCCAG AAGGCAGGGA TTTTCGCCTA 1620
TTTTGTTCAG TGGTGTATCC CCAGTGCCTA AAACATTGCC TGGCAATACA CATTTATTGA 1680
ACTGCTGGAT TTAATTAACT ACTTTGATAT ATGGTCCTAA AGATTCCTGT GCTACCAAAG 1740
TTGCTACTCA GTGGAGCTTC CTGGTGTGGC ATGTTAGAGA AGAGACCAGA AAAACAGACA 1800
TTTCACTTGC TGTCAGGTAG TGAAGGAGCT GTGGCTGCTT GGGCACAGTC ATTACTGTTT 1860
ATTCCACTGT GCTGCACATC TTGAAGCTGT AAAGATATAA GAAGTCTCGC ACAGCCGGGG 1920
TTCAGCTTAC AATCCTTCGC 1940